RELIEF THERAPEUTICS HLDG AG (RLFTF, $4.7) was a top loser this month, diving -1 to $4.7 per share. Of the 859 stocks analyzed in the Biotechnology Industry throughout this month, of them (3) exhibited an Uptrend while of them (6) were in a Downtrend.